Your browser doesn't support javascript.
loading
COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices.
Wang, Zijun; Liu, Hui; Li, Yang; Luo, Xufei; Yang, Nan; Lv, Meng; Zhou, Qi; Li, Qinyuan; Wang, Ling; Zhao, Junxian; Liu, Yunlan; Su, Renfeng; Wu, Shouyuan; Liu, Xiao; Zhao, Siya; Shi, Qianling; Estill, Janne; Liu, Xingrong; Zhang, Wenhong; Chen, Yaolong.
Afiliação
  • Wang Z; Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Lanzhou University Institute of Health Data Science, Lanzhou, China.
  • Liu H; School of Public Health, Lanzhou University, Lanzhou, China.
  • Li Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Luo X; School of Public Health, Lanzhou University, Lanzhou, China.
  • Yang N; Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
  • Lv M; Department of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Zhou Q; Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
  • Li Q; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Wang L; School of Public Health, Lanzhou University, Lanzhou, China.
  • Zhao J; School of Public Health, Lanzhou University, Lanzhou, China.
  • Liu Y; School of Public Health, Lanzhou University, Lanzhou, China.
  • Su R; School of Public Health, Lanzhou University, Lanzhou, China.
  • Wu S; School of Public Health, Lanzhou University, Lanzhou, China.
  • Liu X; School of Public Health, Lanzhou University, Lanzhou, China.
  • Zhao S; School of Public Health, Lanzhou University, Lanzhou, China.
  • Shi Q; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
  • Estill J; Institute of Global Health, University of Geneva, Geneva, Switzerland; Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern, Switzerland.
  • Liu X; School of Public Health, Lanzhou University, Lanzhou, China. Electronic address: liuxr@lzu.edu.cn.
  • Zhang W; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China; National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan
  • Chen Y; Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Lanzhou University Institute of Health Data Science, Lanzhou, China; School of Public Health, Lanzhou University, Lanzhou, China; WHO Collaborating Center for Guideline Implementation and Knowledge
J Clin Epidemiol ; 144: 163-172, 2022 04.
Article em En | MEDLINE | ID: mdl-34920115
OBJECTIVE: To describe the current status of COVID-19 vaccine guidelines. STUDY DESIGN AND SETTING: We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines and extract data of whether the methodology, funding, and conflict of interests were assessed/reported, and so on. Results were presented descriptively. RESULTS: A total of 106 COVID-19 vaccine guidelines were included. In the first half of 2021, on average 15 guidelines were published every month. Fifty (47.2%) guidelines addressed the vaccination of people with specific medical conditions, and 18 (17.0%) guidelines focused on adverse effects after vaccination. Only 28 (26.4%) guidelines reported the methodology they used. Four (3.8%) of guidelines assessed both the quality of evidence and strength of recommendations; 42 (39.6%) and 65 (61.3%) guidelines reported their funding sources and conflict of interest, respectively. Most guidelines were published in English (n = 92, 86.8%). CONCLUSION: A high number of guidelines on COVID-19 vaccines have been published in the recent months, but most of them lack clear and transparent reporting of methodology, funding, and conflicts of interest. Rigorous methodological and reporting quality evaluation of these guidelines is needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Clin Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Clin Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China